Agree with you on this one. Would be useful to know what proportion of surgeries current users are using the Xperience product, how has that trended over time, right now with just a top line revenue number (without product split, or forward guidance) it's very hard for investors to map out the growth. Really need some institutional investors on the register that can give it to the management team and push them to report accurately.
Ann: Investor Presentation, page-5
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.015(10.0%) |
Mkt cap ! $39.44M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 13.5¢ | $119.9K | 836.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28579 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 24827 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NXS (ASX) Chart |